This federal contract award, valued at $8,762.74, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of 4,566,705,223 units of Ondansetron HCl 8 mg tablets. The contract has an ultimate completion date of December 13, 2024 and is a firm fixed-price arrangement.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This specific delivery order falls under the scope of that larger IDC contract. The contract does not have a set-aside designation, indicating open competition.
Generated 3/13/25, 9:48 AM